Preoperative evaluation of pancreatic adenocarcinoma
- 1 July 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Hepato-Biliary-Pancreatic Surgery
- Vol. 15 (4), 429-435
- https://doi.org/10.1007/s00534-007-1240-7
Abstract
The preoperative evaluation of resectability for pancreatic cancer fails to identify up to 25% of patients who are unfortunately found to be unresectable at surgical exploration. Inoperative findings in this circumstance is usually due to either small volume metastatic disease or regional tumor invasion. While advances in computed tomography (CT) technology has increased accuracy of local tumor extent, occult metastatic disease remains a common problem. Although 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) has been demonstrated to be useful in the staging of many malignancies (e.g. esophageal cancer, recurrent colorectal cancer, lung cancer), it has not been found to significantly increase the accuracy of determining resectability preoperatively in pancreatic cancer, especially with regard to detection of small volume metastatic disease. There are a variety of pancreatic cancer-specific antigens which are being developed as a method for targeted molecular imaging; we provide preliminary data targeting the integrin αvβ6 to demonstrate the potential feasibility of this approach. Further developments may allow the accurate determination of patients with resectable pancreatic cancer, and more importantly, those with unresectable disease that may forego unnecessary surgery, the associated morbidity, and the subsequent delay of appropriate therapy.Keywords
This publication has 61 references indexed in Scilit:
- Positron Emission Tomography/Computed Tomography Influences on the Management of Resectable Pancreatic Cancer and Its Cost-EffectivenessAnnals of Surgery, 2005
- Immunohistochemical screening for β6‐integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up‐regulation in pancreatic ductal adenocarcinomas in vivo and in vitroHistopathology, 2004
- Abdominal Imaging with Multidetector Computed TomographyJournal of Computer Assisted Tomography, 2004
- State-of-the-art imaging of pancreatic neoplasmsThe British Journal of Radiology, 2003
- Exploring the Host Desmoplastic Response to Pancreatic CarcinomaThe American Journal of Pathology, 2002
- Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundiceEuropean Journal of Surgical Oncology, 2000
- Is CT angiography sufficient for prediction of resectability of periampullary neoplasms?Journal of Gastrointestinal Surgery, 2000
- Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT.American Journal of Roentgenology, 1997
- FDG-PET Evaluation of Indeterminate Pancreatic MassesJournal of Computer Assisted Tomography, 1996
- PET with fluorine-18 deoxyglucose for pancreatic diseaseThe Lancet, 1992